O
OrbiMed’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-26,100
| Closed | -$2.15M | – | 112 |
|
|
2024
Q2 | $2.15M | Sell |
26,100
-1,252,400
| -98% | -$103M | 0.04% | 97 |
|
|
2024
Q1 | $112M | Sell |
1,278,500
-292,910
| -19% | -$25.6M | 2.05% | 11 |
|
|
2023
Q4 | $152M | Sell |
1,571,410
-43,800
| -3% | -$4.22M | 3.03% | 7 |
|
|
2023
Q3 | $143M | Hold |
1,615,210
| – | – | 3.04% | 6 |
|
|
2023
Q2 | $140M | Hold |
1,615,210
| – | – | 2.54% | 9 |
|
|
2023
Q1 | $157M | Hold |
1,615,210
| – | – | 3.08% | 7 |
|
|
2022
Q4 | $167M | Sell |
1,615,210
-102,100
| -6% | -$10.6M | 3.2% | 6 |
|
|
2022
Q3 | $146K | Buy |
1,717,310
+17,600
| +1% | +$1.49K | 2.7% | 6 |
|
|
2022
Q2 | $141K | Buy |
1,699,710
+52,680
| +3% | +$4.37K | 2.55% | 10 |
|
|
2022
Q1 | $127M | Buy |
1,647,030
+786,150
| +91% | +$60.6M | 2.06% | 15 |
|
|
2021
Q4 | $76.1M | Buy |
860,880
+749,980
| +676% | +$66.3M | 0.98% | 35 |
|
|
2021
Q3 | $8.57M | Buy |
+110,900
| New | +$8.57M | 0.09% | 135 |
|
|
2020
Q2 | – | Sell |
-540,500
| Closed | -$45.7M | – | 137 |
|
|
2020
Q1 | $45.7M | Buy |
540,500
+505,800
| +1,458% | +$42.7M | 0.77% | 42 |
|
|
2019
Q4 | $2.93M | Buy |
+34,700
| New | +$2.93M | 0.04% | 110 |
|
|
2019
Q3 | – | Sell |
-75,000
| Closed | -$6.42M | – | 113 |
|
|
2019
Q2 | $6.42M | Sell |
75,000
-1,500
| -2% | -$128K | 0.1% | 95 |
|
|
2019
Q1 | $6.8M | Hold |
76,500
| – | – | 0.11% | 93 |
|
|
2018
Q4 | $6.51M | Hold |
76,500
| – | – | 0.12% | 93 |
|
|
2018
Q3 | $7.42M | Hold |
76,500
| – | – | 0.09% | 119 |
|
|
2018
Q2 | $7.21M | Sell |
76,500
-69,000
| -47% | -$6.5M | 0.09% | 118 |
|
|
2018
Q1 | $11.8M | Buy |
145,500
+44,900
| +45% | +$3.64M | 0.15% | 100 |
|
|
2017
Q4 | $8.97M | Sell |
100,600
-643,300
| -86% | -$57.4M | 0.11% | 104 |
|
|
2017
Q3 | $69.2M | Sell |
743,900
-238,700
| -24% | -$22.2M | 0.66% | 45 |
|
|
2017
Q2 | $89.2M | Sell |
982,600
-291,500
| -23% | -$26.5M | 0.94% | 35 |
|
|
2017
Q1 | $112M | Hold |
1,274,100
| – | – | 1.27% | 26 |
|
|
2016
Q4 | $106M | Buy |
1,274,100
+122,200
| +11% | +$10.1M | 1.34% | 26 |
|
|
2016
Q3 | $107M | Sell |
1,151,900
-366,600
| -24% | -$33.9M | 1.21% | 27 |
|
|
2016
Q2 | $118M | Buy |
1,518,500
+495,300
| +48% | +$38.5M | 1.23% | 28 |
|
|
2016
Q1 | $84.4M | Buy |
1,023,200
+874,200
| +587% | +$72.1M | 0.89% | 35 |
|
|
2015
Q4 | $15.6M | Sell |
149,000
-39,000
| -21% | -$4.09M | 0.14% | 77 |
|
|
2015
Q3 | $19.8M | Hold |
188,000
| – | – | 0.2% | 75 |
|
|
2015
Q2 | $25.7M | Buy |
+188,000
| New | +$25.7M | 0.21% | 74 |
|
|
2014
Q3 | – | Sell |
-1,435,400
| Closed | -$89.3M | – | 122 |
|
|
2014
Q2 | $89.3M | Sell |
1,435,400
-57,600
| -4% | -$3.58M | 1.05% | 35 |
|
|
2014
Q1 | $102M | Buy |
1,493,000
+78,900
| +6% | +$5.38M | 1.25% | 27 |
|
|
2013
Q4 | $99.5M | Sell |
1,414,100
-167,600
| -11% | -$11.8M | 1.46% | 25 |
|
|
2013
Q3 | $114M | Buy |
1,581,700
+240,500
| +18% | +$17.4M | 2.04% | 17 |
|
|
2013
Q2 | $74.8M | Buy |
+1,341,200
| New | +$74.8M | 1.58% | 23 |
|